EUVIMEDEUVIMED entdecken
Fallbericht

Rituximab as a steroid-sparing drug in recurrent primary focal segmental glomerulosclerosis – a case report

Zofia Kania-Bonicka, Teresa Bączkowska, Krzysztof Mucha

Renal Disease and Transplantation Forum · 13.02.2026 · 19 (1)

DOI: 10.5603/rdatf.112707 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Renal Disease and Transplantation Forum, online erschienen am 13.02.2026. Verfasst von Zofia Kania-Bonicka und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Kania-Bonicka, Z., Bączkowska, T., & Mucha, K. (2026). Rituximab as a steroid-sparing drug in recurrent primary focal segmental glomerulosclerosis – a case report. Renal Disease and Transplantation Forum, 19(1). https://doi.org/10.5603/rdatf.112707

Vancouver

Kania-Bonicka Z, Bączkowska T, Mucha K. Rituximab as a steroid-sparing drug in recurrent primary focal segmental glomerulosclerosis – a case report. Renal Disease and Transplantation Forum. 2026;19(1). doi:10.5603/rdatf.112707

BibTeX
@article{KaniaBonicka2026,
  author = {Kania-Bonicka, Zofia and Bączkowska, Teresa and Mucha, Krzysztof},
  title = {Rituximab as a steroid-sparing drug in recurrent primary focal segmental glomerulosclerosis – a case report},
  journal = {Renal Disease and Transplantation Forum},
  year = {2026},
  volume = {19},
  number = {1},
  doi = {10.5603/rdatf.112707}
}
Kostenlos starten →